DIXENTIL PREVIENE LE DIARREE DA RADIOTERAPIA

Data: 20 Ottobre 2015

Autore: Daniele Scartoni et al. Department of Radiation Oncology, University of Florence

Fonte: www.ncbi.nlm.nih.gov


Scarica l'allegato dello studio

Scarica il pdf

DIXENTIL PREVIENE LE DIARREE DA RADIOTERAPIA

Pubblicato su anticancer research 35: 5687-5692 (2015)

 

Nutritional Supplement Based on Zinc, Prebiotics, Probiotics and Vitamins to Prevent Radiation-related Gastrointestinal Disorders

 

Abstract

Aim: The present phase II study aimed to evaluate the tolerance and safety of Dixentil, a nutritional supplement based on zinc with the addition of prebiotics (galacto-oligosaccharides), tyndalized probiotics (Lactobacillus acidophilus and L. casei) and vitamins B1, B2 and B6, and nicotinamide, given as prophylaxis to patients undergoing pelvic radiotherapy and its efficacy in the prevention and reduction of radiation-related gastrointestinal disorders.

Patients and Methods: Forty consecutive patients who were candidates for pelvic radiotherapy received Dixentil before starting and during radiotherapy. The primary end-point was to evaluate the safety and tolerance of Dixentil. Secondary end-points were incidence and severity of radiation-induced diarrhea and number of patients who discontinued radiotherapy because of diarrhea.

Results: Radiation-induced enteritis occurred in 17 patients, grade I and grade II diarrhea was documented in 14 and 3 patients respectively; no grade III or IV diarrhea was observed. Radiotherapy was discontinued due to orologi replica treatment-induced enteritis only in two patients for 6 days.

Conclusion: Use of Dixentil is an easy, safe, and feasible approach to protect patients against the risk of radiation-induced replica orologi diarrhea.

15/03/2017 OPERA RIDUCE LE NEUROPATIE PERIFERICHE DA CHEMIOTERAPIA

di Isacco Desideri et al- University of Florence


09/10/2015 ORASOL PLUS PREVIENE/RIDUCE LE MUCOSITI DA CHEMIO-RADIOTERAPIA

di Irene Giacomelli et al. Department of Radiation Oncology, University of Florence


08/04/2013 ORASOL PREVIENE LE MUCOSITI IN PAZIENTI SOTTOPOSTI A TRAPIANTO AUTOLOGO

di A. Babic, F. Mariano, L. Orlando - European Institute of Oncology (Milan, IT)


05/11/2017 KUZIK SI DIMOSTRA EFFICACE NELLA PREVENZIONE DELL'EMICRANIA SENZA AURA

di E. Pucci, F. Solinas, C. Mostardini, M. Loiero, D. Soragna, R. Niego, R. Galante


08/05/2019 NAUMIX SI DIMOSTRA UTILE NELLA NAUSEA E DISGEUSIE DA RADIOTERAPIA

di Pierfrancesco Franco- Department of Oncology, Radiation Oncology, University of Turin


08/05/2019 KUZIK SI DIMOSTRA EFFICACE NELLA PREVENZIONE DELL' EMICRANIA SENZA AURA

di Vincenzo Tullo, Marcella Curone,Bruno Colombo,Gianni Allais,Davide Zarcone,Maria Gabriella Saracco,Gennaro Bussone


Prodotti in farmacia

disponibili in farmacia
e parafarmacia